Fontanini G - Search Results

1

Four-modality therapy in malignant pleural mesothelioma: a phase II study.

Lucchi M, Chella A, Melfi F, Dini P, Tibaldi C, Fontanini G, Mussi A. Lucchi M, et al. Among authors: fontanini g. J Thorac Oncol. 2007 Mar;2(3):237-42. doi: 10.1097/JTO.0b013e318031d05c. J Thorac Oncol. 2007. PMID: 17410047 Free article. Clinical Trial.

2

Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.

Fontanini G, Bigini D, Vignati S, Basolo F, Mussi A, Lucchi M, Chine S, Angeletti CA, Harris AL, Bevilacqua G. Fontanini G, et al. J Pathol. 1995 Sep;177(1):57-63. doi: 10.1002/path.1711770110. J Pathol. 1995. PMID: 7472781

3

Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype.

Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi H, Angeletti CA, Pingitore R, Pepe S, Basolo F, Bevilacqua G. Fontanini G, et al. Eur J Cancer. 1995;31A(2):178-83. doi: 10.1016/0959-8049(93)00421-m. Eur J Cancer. 1995. PMID: 7718322

4

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer.

Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Angeletti CA, Basolo F, Bevilacqua G. Fontanini G, et al. Br J Cancer. 1995 May;71(5):1003-7. doi: 10.1038/bjc.1995.193. Br J Cancer. 1995. PMID: 7734290 Free PMC article.

5

Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.

Angeletti CA, Lucchi M, Fontanini G, Mussi A, Chella A, Ribechini A, Vignati S, Bevilacqua G. Angeletti CA, et al. Among authors: fontanini g. Cancer. 1996 Aug 1;78(3):409-15. doi: 10.1002/(SICI)1097-0142(19960801)78:3<409::AID-CNCR5>3.0.CO;2-E. Cancer. 1996. PMID: 8697384

6

Second primary lung cancer and relapse: treatment and follow-up.

Angeletti CA, Mussi A, Janni A, Lucchi M, Ribechini A, Chella A, Fontanini G. Angeletti CA, et al. Among authors: fontanini g. Eur J Cardiothorac Surg. 1995;9(11):607-11. doi: 10.1016/s1010-7940(05)80104-6. Eur J Cardiothorac Surg. 1995. PMID: 8751247

7

Neoangiogenesis: a putative marker of malignancy in non-small-cell lung cancer (NSCLC) development.

Fontanini G, Vignati S, Bigini D, Lucchi M, Mussi A, Basolo F, Angeletti CA, Bevilacqua G. Fontanini G, et al. Int J Cancer. 1996 Sep 4;67(5):615-9. doi: 10.1002/(SICI)1097-0215(19960904)67:5<615::AID-IJC4>3.0.CO;2-X. Int J Cancer. 1996. PMID: 8782647

8

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.

Fontanini G, Vignati S, Lucchi M, Mussi A, Calcinai A, Boldrini L, Chiné S, Silvestri V, Angeletti CA, Basolo F, Bevilacqua G. Fontanini G, et al. Br J Cancer. 1997;75(9):1295-301. doi: 10.1038/bjc.1997.220. Br J Cancer. 1997. PMID: 9155049 Free PMC article.

9

Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.

Fontanini G, Lucchi M, Vignati S, Mussi A, Ciardiello F, De Laurentiis M, De Placido S, Basolo F, Angeletti CA, Bevilacqua G. Fontanini G, et al. J Natl Cancer Inst. 1997 Jun 18;89(12):881-6. doi: 10.1093/jnci/89.12.881. J Natl Cancer Inst. 1997. PMID: 9196255

10

Tumor angiogenesis and biologic markers in resected stage I NSCLC.

Lucchi M, Fontanini G, Mussi A, Vignati S, Ribechini A, Menconi GF, Bevilacqua G, Angeletti CA. Lucchi M, et al. Among authors: fontanini g. Eur J Cardiothorac Surg. 1997 Oct;12(4):535-41. doi: 10.1016/s1010-7940(97)00218-2. Eur J Cardiothorac Surg. 1997. PMID: 9370395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters